Stocks in play: ScreenPro Security Inc.

Announced that further to its press release of February 23rd, 2022, the Company has completed the acquisition of all of the issued and outstanding shares of Add Biomedical Inc, a biomedical screening company specializing in making solutions for disease diagnosis. The Company entered into an amended Share Purchase Agreement with Add Biomedical to acquire the Target shares for a revised purchase price of CAD $3.3 million. The Company is enthusiastic about expanding business lines and looks forward to expanding into the health screening sector, with a focus on breast cancer detection. ScreenPro Security Inc. shares C.SCRN are trading unchanged at $0.05.

Read:

• Reducing the Risks of Adverse Reactions to Covid Vaccines May Also Reduce Hesitancy and Injuries

• Growing Plant-Based Protein Wholesalers Seizing Upon Market’s Appetite for Vegan Options

• Therapy Shake-Up Called for by Mental Health Experts Seeking Solutions for Mental Health Crisis

• Pharmacies and In-Clinic Testing Set to Remain as Covid-19 Numbers Shift into Post-Pandemic Phase

• Biotech Innovators Making Strides Towards Meeting Increased Demand for Breast Cancer Treatments